No Picture
News

New Study Shows Benefit of Using Signatera(TM) Technology for Personalized Monitoring in Gastrointestinal Cancer

Breakthrough blood test detects relapse earlier and helps patients avoid unnecessary clinic visits with GI Expanded Access Program

SAN CARLOS, Calif., April 2, 2020 /PRNewswire/ — A new, peer-reviewed case study published in JCO Precision Oncology1 … […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic

– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating

PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]

No Picture
News

Berkeley Lights Expands Its Platform and Introduces the OptoSeq(TM) 3′ mRNA Library Kit

The OptoSeq 3′ mRNA Library Kit allows users of Berkeley Lights’ platform to efficiently prepare cells of interest for genomic sequencing opening the door to directly link phenotype to genotype using a single system.

EMERYVILLE, Calif., March 31, 202… […]